| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 35.112 | 21.620 | 16.745 | 16.313 | 15.017 | 17.526 | 13.813 | 13.423 | 12.303 | 10.754 |
| Total Income - EUR | 35.147 | 21.969 | 16.745 | 16.442 | 15.017 | 17.526 | 13.813 | 13.423 | 12.303 | 10.754 |
| Total Expenses - EUR | 35.041 | 20.479 | 17.693 | 14.846 | 13.186 | 15.860 | 13.055 | 12.879 | 11.154 | 9.116 |
| Gross Profit/Loss - EUR | 106 | 1.490 | -948 | 1.596 | 1.832 | 1.666 | 758 | 544 | 1.149 | 1.638 |
| Net Profit/Loss - EUR | -949 | 831 | -1.450 | 1.103 | 1.381 | 1.141 | 343 | 142 | 966 | 1.376 |
| Employees | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Farmacia Hypericum S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 397 | 245 | 97 | 59 | 58 | 0 | 0 | 0 | 0 | 0 |
| Current Assets | 11.532 | 5.311 | 7.324 | 7.067 | 8.771 | 9.899 | 9.630 | 9.883 | 10.214 | 9.021 |
| Inventories | 8.565 | 3.860 | 5.060 | 5.671 | 7.858 | 9.095 | 9.073 | 9.163 | 9.250 | 7.545 |
| Receivables | 2.871 | 1.275 | 2.003 | 1.348 | 805 | 661 | 383 | 648 | 912 | 1.431 |
| Cash | 97 | 176 | 261 | 48 | 107 | 143 | 174 | 73 | 52 | 45 |
| Shareholders Funds | 678 | 1.502 | 26 | 1.129 | 2.489 | 1.193 | 1.509 | 1.656 | 2.616 | 3.017 |
| Social Capital | 47 | 47 | 46 | 45 | 44 | 43 | 0 | 43 | 42 | 42 |
| Debts | 11.251 | 4.055 | 7.394 | 5.997 | 6.340 | 8.706 | 8.121 | 8.227 | 7.598 | 6.003 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4773 - 4773" | |||||||||
| CAEN Financial Year |
4711
|
|||||||||
Comments - Farmacia Hypericum S.r.l.